Amicogen Corrects Financials: Net Loss Increases, Equity Decreases

Amicogen's net loss significantly increased due to financial statement correction. Parent company net loss for 26th period: KRW 23.5B (pre-correction KRW 21.2B); 25th period: KRW 39.3B (pre-correction KRW 31.7B).
Additional impairment on subsidiary investments is main cause: KRW 2.3B in 26th period, KRW 7.6B in 25th period.
Parent company total equity decreased: end of 26th period KRW 111.1B (pre-correction KRW 121.0B); end of 25th period KRW 130.0B (pre-correction KRW 137.7B).
Debt ratio increased: end of 26th period 77.68% (pre-correction 71.32%); end of 25th period 101.01% (pre-correction 95.40%).
No dividends paid (no dividends in last 3 years).
Company has contingent liabilities from lawsuits but considers them immaterial.